Literature DB >> 5301733

Antibiotic therapy of cholera in children.

J Lindenbaum, W B Greenough, M R Islam.   

Abstract

In a controlled trial of the effects of oral antibiotics in treating cholera in children in Dacca, East Pakistan, tetracycline was the most effective of 4 antibiotics tested in reducing stool volume, intravenous fluid requirement, and the duration of diarrhoea and positive stool culture. Increasing the duration of tetracycline therapy from 2 to 4 days, or increasing the total dose administered, resulted in shorter duration of positive culture, but did not affect stool volume or duration of diarrhoea. Only 1% of the children receiving tetracycline had diarrhoea for more than 4 days. Tetracycline was significantly more effective than intravenous fluid therapy alone, regardless of severity of disease.Chloramphenicol, while also effective, was inferior to tetracycline. Streptomycin and paromomycin exerted little or no effect on the course of illness or duration of positive culture. Therapeutic failures with these drugs were not due to the development of bacterial resistance.From these findings, tetracycline appears to be the drug of choice against Vibrio cholerae infection in children. Oral therapy for 48 hours is effective clinically, but is associated with 20% bacteriological relapses when the drug is discontinued; it is not known whether extending the therapy for a week or more would eliminate such relapses.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5301733      PMCID: PMC2554369     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  TETRACYCLINE IN THE TREATMENT OF CHOLERA.

Authors:  W B GREENOUGH; R S GORDON; I S ROSENBERG; B I DAVIES; A S BENENSON
Journal:  Lancet       Date:  1964-02-15       Impact factor: 79.321

2.  Cholera in children.

Authors:  J Lindenbaum; R Akbar; R S Gordon; W B Greenough; N Hirschorn; M R Islam
Journal:  Lancet       Date:  1966-05-14       Impact factor: 79.321

3.  Oral streptomycin in the treatment of cholera.

Authors:  C V Uylangco; A E Fabie; S G Mier; L Santiago
Journal:  J Philipp Med Assoc       Date:  1965-11

4.  Tetracycline hydrochloride in the treatment of cholera El Tor.

Authors:  C V Uylangco; J A Vasco; V P Calilong; M P Villaroman
Journal:  J Philipp Med Assoc       Date:  1966-09

5.  Antibiotic therapy of cholera.

Authors:  J Lindenbaum; W B Greenough; M R Islam
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

  5 in total
  13 in total

Review 1.  Cholera.

Authors:  Jason B Harris; Regina C LaRocque; Firdausi Qadri; Edward T Ryan; Stephen B Calderwood
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

2.  Optimal antibiotic therapy in cholera.

Authors:  C K Wallace; P N Anderson; T C Brown; S R Khanra; G W Lewis; N F Pierce; S N Sanyal; G V Segre; R H Waldman
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

3.  Oral (or nasogastric) maintenance therapy for cholera patients in all age-groups.

Authors:  D R Nalin; R A Cash; M Rahman
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

4.  Pediatric cholera.

Authors:  I C Verma
Journal:  Indian J Pediatr       Date:  1970-10       Impact factor: 1.967

Review 5.  Immune responses to cholera in children.

Authors:  Daniel T Leung; Fahima Chowdhury; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Expert Rev Anti Infect Ther       Date:  2012-04       Impact factor: 5.091

6.  Furazolidone in paediatric cholera.

Authors:  A W Karchmer; G T Curlin; M I Huq; N Hirschhorn
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

7.  Tetracycline prophylaxis in families of cholera patients.

Authors:  W M McCormack; A M Chowdhury; N Jahangir; A B Ahmed; W H Mosley
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

Review 8.  Antimicrobial drugs for treating cholera.

Authors:  Ya'ara Leibovici-Weissman; Ami Neuberger; Roni Bitterman; David Sinclair; Mohammed Abdus Salam; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2014-06-19

9.  Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial.

Authors:  G H Rabbani; M R Islam; T Butler; M Shahrier; K Alam
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

10.  Cholera.

Authors:  William Davis; Rupa Narra; Eric D Mintz
Journal:  Curr Epidemiol Rep       Date:  2018-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.